123 related articles for article (PubMed ID: 25869296)
1. Macromolecular glucocorticoid prodrug improves the treatment of dextran sulfate sodium-induced mice ulcerative colitis.
Ren K; Yuan H; Zhang Y; Wei X; Wang D
Clin Immunol; 2015 Sep; 160(1):71-81. PubMed ID: 25869296
[TBL] [Abstract][Full Text] [Related]
2. A Macromolecular Janus Kinase (JAK) Inhibitor Prodrug Effectively Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.
Zhao G; Wei X; Wu J; Eichele DD; Lele SM; Yang L; Zhang F; Wang D
Pharm Res; 2019 Mar; 36(4):64. PubMed ID: 30859327
[TBL] [Abstract][Full Text] [Related]
3. The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model.
Quan L; Zhang Y; Dusad A; Ren K; Purdue PE; Goldring SR; Wang D
Pharm Res; 2016 Jan; 33(1):186-93. PubMed ID: 26286188
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB × NZW)F1 mice without causing systemic side effects.
Yuan F; Nelson RK; Tabor DE; Zhang Y; Akhter MP; Gould KA; Wang D
Arthritis Rheum; 2012 Dec; 64(12):4029-39. PubMed ID: 22886616
[TBL] [Abstract][Full Text] [Related]
5. The effect of dexamethasone treatment on murine colitis.
van Meeteren ME; Meijssen MA; Zijlstra FJ
Scand J Gastroenterol; 2000 May; 35(5):517-21. PubMed ID: 10868455
[TBL] [Abstract][Full Text] [Related]
6. Role of α-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis.
Trivedi PP; Jena GB
Food Chem Toxicol; 2013 Sep; 59():339-55. PubMed ID: 23793040
[TBL] [Abstract][Full Text] [Related]
7. Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy.
Vong LB; Mo J; Abrahamsson B; Nagasaki Y
J Control Release; 2015 Jul; 210():19-25. PubMed ID: 25998050
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Suqingwan watered pill reduces colon injury induced by experimental colitis.
Han N; Li G; Kang R; Li Q; Liu Z; Jiang S; Yin J
J Ethnopharmacol; 2011 Jun; 136(1):144-8. PubMed ID: 21527334
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model.
Gutierrez LS; Ling J; Nye D; Papathomas K; Dickinson C
World J Gastroenterol; 2015 May; 21(20):6157-66. PubMed ID: 26034351
[TBL] [Abstract][Full Text] [Related]
10. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
11. Macromolecular prodrug of dexamethasone prevents particle-induced peri-implant osteolysis with reduced systemic side effects.
Ren K; Dusad A; Yuan F; Yuan H; Purdue PE; Fehringer EV; Garvin KL; Goldring SR; Wang D
J Control Release; 2014 Feb; 175():1-9. PubMed ID: 24326124
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis.
Chen SQ; Song YQ; Wang C; Tao S; Yu FY; Lou HY; Hu FQ; Yuan H
Carbohydr Polym; 2020 Feb; 230():115613. PubMed ID: 31887935
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
14. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.
Zhang S; Ermann J; Succi MD; Zhou A; Hamilton MJ; Cao B; Korzenik JR; Glickman JN; Vemula PK; Glimcher LH; Traverso G; Langer R; Karp JM
Sci Transl Med; 2015 Aug; 7(300):300ra128. PubMed ID: 26268315
[TBL] [Abstract][Full Text] [Related]
15. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy.
Quan LD; Purdue PE; Liu XM; Boska MD; Lele SM; Thiele GM; Mikuls TR; Dou H; Goldring SR; Wang D
Arthritis Res Ther; 2010; 12(5):R170. PubMed ID: 20836843
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.
Cho EJ; Shin JS; Noh YS; Cho YW; Hong SJ; Park JH; Lee JY; Lee JY; Lee KT
J Ethnopharmacol; 2011 Jul; 136(3):428-35. PubMed ID: 20573566
[TBL] [Abstract][Full Text] [Related]
17. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.
Bian Z; Li L; Cui J; Zhang H; Liu Y; Zhang CY; Zen K
J Pathol; 2011 Dec; 225(4):544-53. PubMed ID: 21590770
[TBL] [Abstract][Full Text] [Related]
18. Suppression of mir-150-5p attenuates the anti-inflammatory effect of glucocorticoids in mice with ulcerative colitis.
Wang Y; Qin J; Dong L; He C; Zhang D; Wu X; Li T; Yue H; Mu L; Wang Q; Yang J
Mol Immunol; 2023 Nov; 163():28-38. PubMed ID: 37729776
[TBL] [Abstract][Full Text] [Related]
19. A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression.
McLeod AD; Fedorak RN; Friend DR; Tozer TN; Cui N
Gastroenterology; 1994 Feb; 106(2):405-13. PubMed ID: 7507873
[TBL] [Abstract][Full Text] [Related]
20. Polymeric dexamethasone prodrugs attenuate lupus nephritis in MRL/lpr mice with reduced glucocorticoid toxicity.
Zhao Z; Jiang H; Xu X; Jia Z; Ren R; Foster KW; Wei X; Chen N; Goldring SR; Crow MK; Wang D
Nanomedicine; 2022 Aug; 44():102579. PubMed ID: 35768036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
